Navigation Links
LightPath Technologies Provides Quarterly Update on Infrared Initiatives
Date:10/31/2012

ORLANDO, Fla., Oct. 31, 2012 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath", the "Company" or "we"), a global manufacturer, distributor and integrator of patented optical components and high-level assemblies, today provided an update to shareholders on its progress with its infrared lens initiatives.  

(Logo: http://photos.prnewswire.com/prnh/20120202/FL45310LOGO )

LightPath continues to develop its thermal imaging business and is currently in the later stages of upgrading manufacturing capabilities at its Orlando factory to support the anticipated growth in its thermal infrared product lines. Sales and technical teams have been in contact with many large OEMs who purchase infrared optics in this space and LightPath has received initial orders from three such OEMs for prototypes of optical assemblies for their respective thermal imaging systems. LightPath's optics provide significant material cost advantages for its customers through the use of chalcogenide glass compared to the materials that are currently in use today for such systems. LightPath continues to see significant growth opportunities for this business and expects significant orders from these and other customers in the second half of fiscal 2013. 

In addition, the infrared development program with Raytheon Vision Systems continues to progress and work is now shifting from producing initial prototypes to developing the necessary production-scale cost reductions to meet the program's cost and performance goals. With a substantial portion of the investment phase now completed, core manufacturing techniques and resources are now in place with significant improvements having been made in the protective coatings for the lenses. As the cost reductions are developed from this work, they are being implemented into LightPath's proprietary process.

Jim Gaynor, President and Chief Executive Officer of LightPath, commented, "We are excited by the growing acceptance of the infrared products we offer as we continue to successfully penetrate this $150 million addressable market serving a diverse customer base. In particular, we see our infrared business being driven by demand for our quantum cascade laser lenses, with interest from customers in various subsectors, such as infrared countermeasures, gas analysis and spectroscopy."

About LightPath TechnologiesLightPath manufactures optical products including precision molded aspheric optics, GRADIUM® glass products, proprietary collimator assemblies, laser components utilizing proprietary automation technology, higher-level assemblies and packing solutions. The Company's products are used in various markets, including industrial, medical, defense, test and measurement and telecommunications. LightPath has a strong patent portfolio that has been granted or licensed to it in these fields. For more information visit www.lightpath.com.

Forward-Looking StatementsThis news release includes statements that constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding our ability to expand our presence in certain markets, future sales growth, continuing reductions in cash usage and implementation of new distribution channels. This information may involve risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, factors detailed by LightPath Technologies, Inc. in its public filings with the Securities and Exchange Commission. Except as required under the federal securities laws and the rules and regulations of the Securities and Exchange Commission, we do not have any intention or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.Contacts: Jim Gaynor, President & CEO

Dorothy Cipolla, CFOLightPath Technologies, Inc.

LightPath Technologies, Inc. Tel: 407-382-4003

Tel: 407-382-4003 x305Email: jgaynor@lightpath.com 

Email: dcipolla@lightpath.com  Web: www.lightpath.com 

Web: www.lightpath.comBrett Maas, Managing Partner Hayden IR Tel: 646-536-7331 Email: Brett@haydenir.com Web: www.haydenir.com
'/>"/>

SOURCE LightPath Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global eClinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies: MarketResearchReports.Biz
2. Harvest Technologies Corporation reicht Patentverletzungsklage gegen ThermoGenesis Corporation ein
3. Harvest Technologies Corporation Files Patent Infringement Complaint against ThermoGenesis Corporation
4. Pathogenica and Life Technologies EMEA Partner to Control Hospital Acquired Infections
5. DiFUSION Technologies Announces Breakthrough Medical Polymer
6. Top 10 Drug Delivery Technologies (2010 - 2015)
7. Lifeline Biotechnologies Receives Third Software Patent
8. Creation Technologies Expands Its China Manufacturing Footprint
9. Life Technologies to Partner with Bristol-Myers Squibb for Companion Diagnostics Development
10. Life Technologies Begins Shipping Ion Proton System
11. Terso Solutions partners with Champion Medical Technologies to offer fully automated tracking of Tissue and Implantable Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):